Cedar Mountain Advisors’s DexCom DXCM Stock Holding History

Cedar Mountain Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.39K	Hold	80	–	–	﹤0.01%	660
2026 Q1	$5.02K	Buy	+80	New	+$5.57K	﹤0.01%	652

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cedar Mountain Advisors's DXCM Position: Q2 2026 in Review

Cedar Mountain Advisors held its DexCom (DXCM) position steady in Q2 2026 at 80 shares worth $5.39K. The position accounts for ﹤0.01% of the portfolio, ranked #660.

Cedar Mountain Advisors first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Cedar Mountain Advisors held 80 shares of DexCom worth $5.39K as of Q2 2026.
Cedar Mountain Advisors left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #660 holding.
Cedar Mountain Advisors first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.